chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever; chills; This is a spontaneous report from a contactable consumer (Patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number and Expiry date was not reported), via an unspecified route of administration on unspecified date as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications was not reported. On unspecified date, the patient experienced fever and chills. Event took place after use of product. The outcome for the events fever and chills was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Chest pressure or tightness in chest; Fever; Chills; A spontaneous report was received from a consumer concerning a 30-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events chest pressure or tightness in chest/ chest discomfort, chills, fever.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 18 Jan 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 013L20A) via unknown route for prophylaxis of COVID-19 infection. On 15 Feb 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: 015N20A) via unknown route for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the events chest pressure or tightness in chest, chills, fever.  Treatment details included Has taken Tylenol and Advil.  The patient received both scheduled doses of mRNA-1273 prior to the events, therefore, the action taken with the drug in response to the events was not applicable.   The outcome of events, chest pressure or tightness in chest, chills, fever was unknown.
pt had vax @ approx 1015AM went to ladies room-states felt badly & collapsed on floor-pale & cold-pulse 72 10:30 pulse 64;vomited large amt;undigested food-bile colored 10:35 MD in attendance BP 120/70 pulse 88;OJ & water;
7 days after receiving the Jansen shot, I experienced sharp pains in my stomach. This escalated to pains in my chest, shortness of breath, pain in my throat, difficulty breathing, swelling in the hands and feet, pain at the bottom of my feet, a swollen lip, and headaches. Some of these symptoms, which started on Saturday, April 10th, have persisted until today, Wednesday, April 14th.  The most pronounced symptom that remains is labored breathing and chest pain. I do not have any known allergies to food or medicine and have never had an allergic response like this before. I visited the ER on April 12th and April 13th for treatment, and was prescribed 20 mg of Prednisone (2 tablet every day for 4 days).  My D-Dimer was elevated but I did not have a blood clot.
low grade fever 99.8-100.2 AND two red raised hive like bumps near injection site measuring approximately 1.25"x1" and 1"x .75". Acetaminophen was taken for the fever.  Red Bumps have not gone away yet.
About 10 mins. after my shot, I got a headache. They gave me a lollipop and I felt better. Told me to take one Advil and to hydrate with Pedialyte and water. Waited another 15-20 mins. and left. Went to pick up Pedialyte and started to drive to work. Started itching all over- head, face, nose, neck, arms, hands, stomach, legs and feet. My lips felt swollen or chapped. Looked in the mirror and saw a little bit of a rash on my forehead, temples and left jawline. Drove to the pharmacist and she said it was a reaction, not a side affect. Told me to take Benadryl and if I didn't feel better to go to the hospital.  Took an Advil, Benadryl and drank Pedialyte-- felt better. Took the Benadryl and Pedialyte all day Thursday and Friday. Saturday only Pedialyte. Today, Sunday, I am itchy again. Feels like something is biting me and have a few welts or pimple like bumps. Will start taking Benadryl now.
I was having a sore throat it was dry scratchy and weird. It lasted all day and that evening I took a home COVID-19 test, and it was positive. I had a brain fog and muscle aches in my head neck and shoulders. From the 15th through the 22nd I had postnasal drip, a headache with pressure behind my eyes, I was sneezing, I had chills and night sweats, my nasal passages were inflamed painful and burning, I also had the worst of it all through the 17th but from then on, I felt better and better each day. I really just quarantined and stayed home, stayed hydrated, and slept and I felt that it was just a horrible sickness, and I was really sick.
tinnitus for 24 hours, loss of hearing for 48 hours, tinnitus for about 7 days. Received second dose on 2/3/21, Lot# EL3289, tinnitus restarted at about 24 hours post-vaccine. No improvement and tinnitus continues. All symptoms only in right ear.
pea sized erythema, tenderness & swelling, mild fever, 4 days p/inj;few more days later swelling from upper arm to elbow devel w/patchy erythema;several med prescribed including ATB & steroids;ultrasound performed revealed swelled tissue
firm, erythematous, warm raised area over rt deltoid; 6cm in diameter w/2 erythematous areas extending forward under axilla-painful
This is a spontaneous report from a contactable nurse. A 21-year-old male patient received the first dose of TRUMENBA (Lot Number M95612, Expiry date Jul2017), intramuscular at 0.5 ml single in the left deltoid on 01Jun2016 at 16:00. Medical history included asthma on ongoing (Does not know when diagnosed). Concomitant medication included BASIC, on ongoing for allergies. On 01Jun2016, the patient experienced numbness and tingling at injection site, pain, chills, fever, feels rotten. Also he developed nausea and headache on an unspecified date. The outcome of the events was unknown. Follow-up (29JUL2016): Follow-up attempts are completed. No further information is expected.
Father states she felt warm 3 days after vaccine approximately. Had fever (face warm off and on -doing better today, but her hard jerks started at 1AM and dad noticed it in her sleep 1+ entire today. Otherwise sit, normal+ eating well today. First PC was 1.5-2.0 years ago. Taken to ER. Dr states viral respiratory illness. Will go to COH. 3-14-04: dad states she's better. Did not go to Dr. Father states he doesn't feel symptoms are vaccine related.
The day after the shot, I experienced severe joint and muscle pain.  It was excruciating.  I was able to finally get comfortable around midnight that night with some Tylenol.  Woke up on day 2 with Moderate joint and muscle pain.  Was able to help with Tylenol.
No additional AE reported; vaccine was improperly stored and administered; This spontaneous report was received from a medical assistant, who refers to a patient of unknown age or gender. Information regarding the patient's drug reactions or allergies, concomitant therapies and pertinent medical history was not provided. On 11-JAN-2021, the patient received a dose of an improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB), dose reported as 0.5 ml, lot # T011167, expiry date 27-MAY-2022, for prophylaxis (formulation, concentration, dose number, route of administration and frequency were not reported). Digital data logger was involved. The vaccine underwent the temperature excursion below36 degrees of Fahrenheit (F) (35.70F) for 1 hour and 30 minutes on 27-OCT-2020 and below 36 F (30.20F) for 1 hour and 30 minutes on 28-OCT-2020. There was previous temperature excursion on 14-OCT-2020: the vaccine underwent the temperature excursion above 47F (64.36 F) for 3 hours. No additional adverse effects were reported. No product quality complaint (PQC) was involved.
Initial report received on 16 November 2009 from a consumer's spouse. A 50-year-old male patient, who has seasonal allergies, had received an intramuscular right deltoid injection of FLUZONE 2009-2010 (lot number U3260EA) on 09 November 2009. Four hours post-vaccination the patient complained of a "weird feeling in throat" so he took BENADRYL 50mg. Both eyes became blood shot and were tearing. His lower lip became numb and his tongue was swollen. The patient went to the emergency room. At that time, his blood pressure was increased (reading not provided) and he was administered SOLUMEDROL, PEPCID and "saline." The patient then developed chills and sweats. By the next morning, all symptoms had resolved. Documents held by sender: None.
pt recv vax & exp gen rash;the nurse reported a total of 6 patients w/same experience;
Patient received her 2nd shot on 5/5 and noted that within 48 hrs she experienced low grade fever up to 99 F, rash at the injection site, R earache, on/off sore throat and the glands on both sides of her neck were swollen. Patient states that within 5 days her fever and rash had resolved but her other symptoms have persisted. She is concerned the most about the persistent lymphadenopathy. She has not taken anything over the counter for the symptoms as of her visit to the provider.
superficial thrombophlebitis of left calf seen in an urgent care. treated with heat packs/cold packs. encouraged to follow up with clinic because of concerns
Skin rash appeared on both legs that appears splotchy and moves around. Never spread above the knee. Painful, itchy, and burns occasionally. Skin is red and slightly inflamed. Antibiotics have had no effect on the rash.
Pt recv vax & devel inj site rxn of redness,warmth,itching & a lump. This is 1 of 3 pt to have adverse rxn p/vax w/lot# 4968263
Pt's father reports that for 2 days, the pt had eruption of papules on trunk, extremities and face (some weeping with fluid). Treated with calamine lotion and Aveeno bath and Tylenol if has a fever.
chills, weakness and severe muscle cramps that showed up 5 hours after vaccination and lasted for 4 days; thrombocytopenia that was detected by labs a few days after vaccination, labs 1-2 days later showed a return of platelets, so no treatment was recommended. Complete loss of hearing in left ear and some degree of loss in right ear within 3 months after vaccination. Tinnitus has gotten worse in the same time as the hearing loss.
This spontaneous report as received from a healthcare worker refers to a 1 year old patient of unknown gender. No medical history and concurrent conditions were reported. On an unknown date the patient was vaccinated with PROQUAD (Merck) (Lot number and expiry date unknown) (dosing regimen and frequency unknown) and VARIVAX (Merck) (Lot number and expiry date unknown) (dosing regimen and frequency unknown) instead of VARIVAX (Merck) and the prescribed dose of M-M-R II. No concomitant medications were reported. No adverse effect was reported. The action taken with the therapy with PROQUAD (Merck) and VARIVAX (Merck) was unknown. There was no product quality issue reported. Additional information has been requested.
Small Rash; Itchiness; This is spontaneous report received from a contactable female consumer or other non-health care professional (Patient). A female patient of an unspecified age received bnt162b2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection; Batch/Lot number was not reported) via an unspecified route of administration on 16Apr2021 as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. Patient received bnt162b2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection; Batch/Lot number was not reported) via an unspecified route of administration on 07May2021 as dose 2, single for covid-19 immunization. On an unspecified date, the patient reported that she had experienced small rash and itchiness. The patient wanted to know if she could take Benadryl for the reported events. The outcome of events was unknown.  No Follow-up attempts are needed. Information about lot/batch number cannot be obtained. No further information is expected.
Injection site pain, headache, malaise, joint swelling/pain, testicular pain, general body pain
FLU LIKE SYMPTOMS; MINOR BODY ACHE; FATIGUE; DIARRHEA; This spontaneous report received from a patient concerned a 38 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A, and expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 11-APR-2021, the subject experienced diarrhea. On 11-APR-2021, the subject experienced minor body ache. On 11-APR-2021, the subject experienced fatigue. On an unspecified date, the subject experienced flu like symptoms. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from diarrhea, and fatigue on 12-APR-2021, and the outcome of flu like symptoms and minor body ache was not reported. This report was non-serious.
HAIR FALLING OUT; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced hair falling out. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of hair falling out was not reported. This report was non-serious.
Soreness at injection site x 48 hours--no treatment Slight twitching in left eyelid x 48 hours--no treatment--still have a little twitching in the eye but seems to be getting better
Information has been received from a registered nurse referring to a patient of unknown age and gender. On 24-FEB-2015, the patient was vaccinated with improperly stored MMR II (therapy type and dose not provided, lot number #K005431, expiration date 15-APR-2016) for routine vaccination. No adverse effects were reported. This is one of several received from the same source. Additional information has been requested.
PATIENT HAS GOTTEN SHINGLES MULTIPLE TIMES SINCE RECEIVING THE VACCINE AND WAS CURRENTLY SEEN AT THE EMERGENCY ROOM. HER BLOOD PRESSURE WAS EXTREMELY HIGH IN STROKE STAGE AND IS ON STRONG PAIN MEDICINE TO KEEP HER COMFORTABLE AT THIS POINT.
Information has been received from a physician concerning a 13 year old female who in February 2007 "within the last month", was vaccinated IM with a first 0.5 ml dose of Gardasil (yeast). There was no concomitant medication. "Within 24 hours post vaccination" the patient experienced nausea, dizziness, and fatigue, which lasted until the next day. Unspecified medical attention was sought. No treatment was given. No product quality complaint was involved. Additional information has been requested.
Lightheaded, dizzy, approx 3 minutes. BP, HR WNL.
I have had period spotting since the day after receiving the first vaccination despite being on my regularly dosed birth control.
Pt is approximately 5 months pregnant. She started experiencing dizziness, sweatiness, warmth, and heavy feeling to her body about 5 minutes after receiving the vaccine. Patient has a history of anxiety. After resting in the counseling for about 10 minutes. Patient reported feeling better. Water bottle was given to her and she was observed at all times. Pt reported her first reaction to the Pfizer vaccine was a sore arm.
scale of 7 out of 10 was an increase in pain/ has been in a mild flare ever since; This is a spontaneous report received from contactable consumer for a Pfizer sponsored program. The reporter is the patient.  A 63-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administration date Sep2021 (Batch/Lot number: unknown) as dose 3 (booster), single for COVID-19 immunisation. Relevant medical history included: "pain" (unspecified if ongoing). Concomitant medication included: XELJANZ, start date: Jan2018 (ongoing). Vaccination history included: BNT162B2 (dose 1, Batch/Lot number: unknown), for COVID-19 immunisation; BNT162B2 (dose 2, Batch/Lot number: unknown), for COVID-19 immunisation. The following information was reported: PAIN (non-serious) with onset 2021, outcome "recovering", described as "scale of 7 out of 10 was an increase in pain/ has been in a mild flare ever since". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient stated scale of 7 out of 10 was an increase in pain. The patient received Pfizer booster vaccine for COVID around 3 weeks prior and has been in a mild flare ever since. The patient stated flare was starting to subside. She has not missed any doses of tofacitinib citrate (XELJANZ) while receiving booster dose per prescriber orders. The patient stated prescriber was aware of current flare.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
describes lightheadedness, sweating, feeling shaky;pt states felt like when had CT scan dye (1984);
Patient tested positive for Covid19 even after being vaccinated with Pfizer EUA 03/10/2021-04/08/2021
Information has been received from a nurse referring to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not provided. On 27-SEP-2016, the patient received an improperly stored dose of ZOSTAVAX (lot number # L039096, expiration date 08-JAN-2017, dose and route not provided). Concomitant therapies were not provided. No adverse effects were reported. Temperature: 15 F; Time Frame: 45 minutes; Was call because of a data logger? Yes; Was it administered (AE)? Yes; Was previous temperature excursion? No Additional information has been requested.
Pt recvd Hep B vax & devel rash; pt was referred to an allergist for treatment; No further details were provided;
Information has been received from a health professional concerning a 70 year old white female with no medical history who on 10/30/03 at 3:15pm, was vaccinated IM in the left deltoid with a 0.5mL second dose of pneumococcal 23v polysaccharide vaccine (Lot # 345255/1212M). There was no illness at the time of vaccination. The first dose was given in 1998. Subsequently, the pt experienced hot, red, swollen and painful arm. Unspecified medical attention was sought. No lab diagnostics were performed and no treatment was required. No product quality complaint was involved.  The reporter expressed a concern with the lot. This is 1 of a total of 5 pt's reported. The records of testing prior to release of this lot have been checked by Quality Assurance and found to be satisfactory. The lot complies with the standards of the Center for Biologics Evaluation and Research and was released. Follow up information indicated that on 11/03/03 at 10:00am the pt had a "reaction to the Pneumovax" and had a very swollen and red arm. She went to a physician who gave her Zithromax. It was reported that it was "now pale pink-still sore". It was reported that on 11/05/03 the pt had recovered. The other pt's (WAES # 0311USA00667, 0312USA02367, 0312USA02368 & 0312USA02369) were vaccinated with pneumococcal 23v polysaccharide vaccine and had the same reaction.  Additional information is not expected.
Visited an ENT Specialist due to the "ringing" in the ears and was told nothing can be done to help with this issue.
This spontaneous report as received from a registered nurse via company representative refers to a 18 year old female patient. It was reported that the patient received two complete, three dose series injections of GARDASIL from two different HCP's. The first series of three GARDASIL injections were given on 10-SEP-2009; 09-NOV-2009; and 23-MAR-2010 (intramuscularly, dose, lot numbers and expiration dates were not provided), at the patient's pediatric office. The second series of three GARDASIL injections were given on 04-JUN-2012, 15-SEP-2014, and 18-NOV-2014 (intramuscularly, dose, lot numbers and expiration dates were not provided), at the patient's gynecologists office. The patient did not seek medical attention. No treatment was given. No AE effects reported. Additional information has been requested.
minor one day reaction/minor one day reaction (unknown related to which vaccine); This spontaneous case was reported by a patient and describes the occurrence of IMMUNISATION REACTION (minor one day reaction/minor one day reaction (unknown related to which vaccine)) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002M21A, 27C21A, 021B21A and 012A21A) for COVID-19 prophylaxis.     Patient has not tested positive for COVID-19.  Concurrent medical conditions included Coronary artery disease, Hypertension, Sleep apnea and Drug allergy (ophthalmic drops for pupils dilatation). Concomitant products included APIXABAN (ELIQUIS), LATANOPROST, SPIRONOLACTONE, LOSARTAN POTASSIUM, CHLORTALIDONE (CHLORTHALIDONE) and ATORVASTATIN for an unknown indication.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Apr-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced IMMUNISATION REACTION (minor one day reaction/minor one day reaction (unknown related to which vaccine)). On 01-Apr-2022, IMMUNISATION REACTION (minor one day reaction/minor one day reaction (unknown related to which vaccine)) had resolved.            No concomitant medications were reported. Caller mentioned he experienced a minor one day reaction after the 2nd booster Patient did not take any treatment for the symptoms.   This case was linked to MOD-2022-672872 (Patient Link).
Information has been received from a certified medical assistant concerning a patient who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck).  Subsequently, about 5 days after receiving the vaccination, the patient developed a rash covering his/her entire body.  The patient was sent to the lab for blood draw, but nobody would draw blood until 4 days later when the rash subsided.  No further information was available.  Unspecified medical attention was sought.  There was no product quality complaint.  Additional information has been requested.
Thrombocytopenia purpura. Doc 201737 reports that patient required IV Ig for thrombocytopenia and has recovered. However has had intermittent joint aches which are ongoing which is unknown if this is to reaction to vaccines
Patient states he has a lump under the skin near his left clavicle that appeared the day following the administration of his Moderna covid-19 vaccine. Patient states the lump is "hardish" and about the size of an Advil liquid gel. He ranked his pain/discomfort as a 1 out of 10. I advised him to contact is PCP for further evaluation.
Patient was stating that he was experiencing chest pain today after his immunization. He was advised to contact his doctor office for further evaluation.